US Equities
Dynavax Technologies (DVAX) Stock Reduced This Year’s Loss To 2%, Hepatitis Vaccine Approved In Europe
Dynavax Technologies Corporation (DVAX) has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has approved the application of the HEPLISAV-B vaccine to prevent hepatitis B. In the United States, the HEPLISAV-B vaccine was approved in 2017. It
